Premium
Clinical impact of multiple DNA virus infections in nondepleted haploidentical and unrelated allogeneic hematopoietic stem cell transplantation
Author(s) -
Kerbauy Maria.,
Ribeiro Andreza A. F.,
Arcuri Leonardo J.,
Kerbauy Lucila N.,
Silva Cinthya C.,
Camargo Luis Fernando A.,
Machado Clarisse M.,
Hamerschlak Nelson
Publication year - 2021
Publication title -
transplant infectious disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.69
H-Index - 67
eISSN - 1399-3062
pISSN - 1398-2273
DOI - 10.1111/tid.13626
Subject(s) - medicine , hematopoietic stem cell transplantation , hazard ratio , cumulative incidence , transplantation , thymoglobulin , viral load , cyclophosphamide , immunology , gastroenterology , cytomegalovirus , confidence interval , virus , herpesviridae , viral disease , chemotherapy , kidney transplantation
Few studies have compared the clinical impact of multiple DNA‐virus infections in haploidentical hematopoietic stem cell transplantation (haplo‐HSCT) with posttransplant cyclophosphamide (PTCy) and unrelated donor allogeneic hematopoietic stem cell transplantation (UD‐HSCT) with thymoglobulin, so we retrospectively analyzed viral infections in the first 6 mo posttransplant in these scenarios. Fifty‐nine patients underwent to haplo‐HSCT, and 68 to UD‐HSCT. The most frequent infection was cytomegalovirus (CMV) (76.3% in haplo‐HSCT and 69.1% in UD‐HSCT) ( P = .878) and in the group of patients with CMV reactivation, maximal CMV viral load over 2500 UI/ml correlated with worse overall survival‐hazard ratio (HR) 1.93 (95% confidence interval [CI] 1.04‐3.59) P = .03. The cumulative incidence of multiple DNA virus within 180 d of posttransplant was 78.7% for one virus and 28.4% for two or more viruses with no difference regarding the type of transplant. Viral infections, age, and acute graft versus host disease (GVHD) grades II–IV were risk factors for worse overall survival in multivariate analyses: one virus HR 2.53 (95% CI 1.03‐6.17) P = .04, two or more viruses HR 3.51 (95% CI 1.37‐9) P < .01, age HR 1.03 (95% CI 1.02‐1.05) P < .01 and acute GVHD II–IV HR 1.97 (95% CI 1.13‐3.43) P = .01. Also, age over 50 y HR 4.25 (95% CI 2.01‐8.97) P < .001, second CMV reactivation or having both CMV and BK polyomavirus (BKV) HR 2.65 (95% CI 1.26‐5.56) P = .01 and acute GVHD grades II–IV HR 2.23 (95% CI 1.12‐4.43) P = .022 were risk factors for nonrelapse mortality in the multivariate analyses. In conclusion, multiple DNA‐virus infections are frequent in both haplo‐HSCT and UD‐HSCT and a risk factor for worse overall survival.